Predictive Nomogram for Evaluating Survival in Patients with Spinal Metastases
Article Sidebar
Main Article Content
Abstract
Objective: To evaluate patients with spinal metastases who underwent surgery, evaluating survival according to the SORG (Skeletal Oncology Research Group) Nomogram.
Materiales and Methods: Retrospective study, March 2017 to March 2019. 20 patients. Inclusion criteria: spinal metastases, with or without spinal compression. Evaluation parameters: the SORG Nomogram with probability of survival, at 30, 90 and 365 days, in the preoperative phase and the remote evaluation: survival to March 2020.
Results: 14 women and 6 men, average age: 67.9 years. Follow-up 6 to 36 months. Average final score: 222.4 points, which would be equivalent to a survival of 99% after a month, 78% after 3 months and 50% after a year.
Conclusion: In cancer patients with spinal metastases, the SORG nomogram would be useful to predict survival, especially at one year.Level of Evidence: IV
Downloads
Metrics
Article Details
Manuscript acceptance by the Journal implies the simultaneous non-submission to any other journal or publishing house. The RAAOT is under the Licencia Creative Commnos Atribución-NoComercial-Compartir Obras Derivadas Igual 4.0 Internacional (CC-BY-NC.SA 4.0) (http://creativecommons.org/licences/by-nc-sa/4.0/deed.es). Articles can be shared, copied, distributed, modified, altered, transformed into a derivative work, executed and publicly communicated, provided a) the authors and the original publication (Journal, Publisher and URL) are mentioned, b) they are not used for commercial purposes, c) the same terms of the license are maintained.
In the event that the manuscript is approved for its next publication, the authors retain the copyright and will assign to the journal the rights of publication, edition, reproduction, distribution, exhibition and communication at a national and international level in the different databases. data, repositories and portals.
It is hereby stated that the mentioned manuscript has not been published and that it is not being printed in any other national or foreign journal.
The authors hereby accept the necessary modifications, suggested by the reviewers, in order to adapt the manuscript to the style and publication rules of this Journal.
References
metastatic spine tumor prognosis. Spine (Phila Pa 1976) 1990;15(11):1110-3. https://doi.org/10.1097/00007632-
199011010-00005
2. Tokuhashi Y, Matsuzaki H, Oda H, Oshima M, Ryu J. A revised scoring system for preoperative evaluation
of metastatic spine tumor prognosis. Spine (Phila Pa 1976) 2005;30(19):2186-91. https://doi.org/10.1097/01.
brs.0000180401.06919.a5
3. Bauer HC, Wedin R. Survival after surgery for spinal and extremity metastases. Prognostication in 241 patients.
Acta Orthop Scand 1995;66(2):143-6. https://doi.org/10.3109/17453679508995508
4. Tomita K, Kawahara N, Kobayashi T, Yoshida A, Murakami H, Akamaru T. Surgical strategy for spinal metastases. Spine (Phila Pa 1976) 2001;26(3):298-306. https://doi.org/10.1097/00007632-200102010-00016
5. Ghori AK, Leonard DA, Schoenfeld AJ. Modeling 1-year survival after surgery on the metastatic spine. Spine J
2015;15(11):2345-50. https://doi.org/10.1016/j.spinee.2015.06.061
6. Leithner A, Radl R, Gruber G, Windhager R. Predictive value of seven preoperative prognostic scoring systems for spinal metastases. Eur Spine J 2008;17(11):1488-95. https://doi.org/10.1007/s00586-008-0763-1
7. Zoccali C, Skoch J, Borgstrom M, Baaj A. The Tokuhashi score: effectiveness and pitfalls. Eur Spine J
2016;25(3):673-8. https://doi.org/10.1007/s00586-015-4339-6
8. Paulino Pereira NR, Mclaughlin L, Janssen SJ, van Dijk CN, Bramer JAM, Laufer I, et al. The SORG nomogram
accurately predicts 3- and 12-months survival for operable spine metastatic disease: External validation. J Surg
Oncol 2017;115(8):1019-27. https://doi.org/10.1002/jso.24620